Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years
FI: 2,674
Type: Letter
Collaboration
Year: 2019
Writers
Provencio, M; Franco, F; Gomez-Codina, J; White, CQ; Llanos, M; Garcia-Arroyo, F; de la Cruz, L; Guma, J; Delgado, JR; Alvarez, R; Chacon, JI; Royuela, A; Wheel, A
Magazine
Title: LEUKEMIA & LYMPHOMA
Quartile
- Q3